𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Axon cytoskeleton ultrastructure in chronic inflammatory demyelinating polyneuropathy

✍ Scribed by Catherine Fressinaud; Frédéric Dubas

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
463 KB
Volume
44
Category
Article
ISSN
0148-639X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vestibular dysfunction in chronic inflam
Vestibular dysfunction in chronic inflammatory demyelinating Polyneuropathy
✍ Elliot M. Frohman; Ronald Tusa; Alexander S. Mark; Dr David R. Cornblath 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 794 KB

Chronic inflammatory demyelinating polyneuropathy (CIDP) has occasionally been associated with clinical or laboratory evidence (magnetic resonance imaging, [MRI], visual evoked response, and brainstem auditory evoked response [BAER]) of cranial neuropathy. In most cases, the relationship of cranial

Restless legs syndrome in chronic inflam
Restless legs syndrome in chronic inflammatory demyelinating polyneuropathy
✍ Yusuf A. Rajabally; Rahul S. Shah 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

## Abstract The prevalence of restless legs syndrome (RLS) is unknown in chronic inflammatory demyelinating polyneuropathy (CIDP). We prospectively studied 28 patients with CIDP. Prevalence of RLS in CIDP was ascertained by face‐to‐face interview using validated criteria and compared with that in 2

Electrophysiology in chronic inflammator
Electrophysiology in chronic inflammatory demyelinating polyneuropathy with IGIV
✍ Vera Bril; Hans Katzberg; Peter Donofrio; Marta Banach; Marinos C. Dalakas; Chun 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

## Abstract Patients with chronic inflammatory demyelinating polyneuropathy (CIDP) received immune globulin intravenous, 10% caprylate/chromatography purified (IGIV‐C, Gamunex; __n__ = 59) or placebo (__n__ = 58) every 3 weeks for up to 24 weeks (first period) in a randomized, double‐blind, paralle